Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 174

1.
2.

Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation.

Lacek K, Urbanowicz RA, Troise F, De Lorenzo C, Severino V, Di Maro A, Tarr AW, Ferrara F, Ploss A, Temperton N, Ball JK, Nicosia A, Cortese R, Pessi A.

J Biol Chem. 2014 Dec 12;289(50):35015-28. doi: 10.1074/jbc.M114.591826. Epub 2014 Oct 23.

PMID:
25342747
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization.

Kim AS, Leaman DP, Zwick MB.

PLoS Pathog. 2014 Jul 24;10(7):e1004271. doi: 10.1371/journal.ppat.1004271. eCollection 2014 Jul.

PMID:
25058619
[PubMed - in process]
Free PMC Article
4.

Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer.

Nkolola JP, Bricault CA, Cheung A, Shields J, Perry J, Kovacs JM, Giorgi E, van Winsen M, Apetri A, Brinkman-van der Linden EC, Chen B, Korber B, Seaman MS, Barouch DH.

J Virol. 2014 Sep 1;88(17):9538-52. doi: 10.1128/JVI.01739-14. Epub 2014 Jun 25.

PMID:
24965452
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.

Venditto VJ, Wieczorek L, Molnar S, Teque F, Landucci G, Watson DS, Forthal D, Polonis VR, Levy JA, Szoka FC Jr.

Clin Vaccine Immunol. 2014 Aug;21(8):1086-93. doi: 10.1128/CVI.00320-14. Epub 2014 May 28.

PMID:
24872518
[PubMed - in process]
Free PMC Article
6.

Preventive and therapeutic applications of neutralizing antibodies to Human Immunodeficiency Virus Type 1 (HIV-1).

Ringe R, Bhattacharya J.

Ther Adv Vaccines. 2013 Jul;1(2):67-80. doi: 10.1177/2051013613494534.

PMID:
24757516
[PubMed]
Free PMC Article
7.

Estimating the probability of polyreactive antibodies 4E10 and 2F5 disabling a gp41 trimer after T cell-HIV adhesion.

Hu B, Liao HX, Alam SM, Goldstein B.

PLoS Comput Biol. 2014 Jan 30;10(1):e1003431. doi: 10.1371/journal.pcbi.1003431. eCollection 2014 Jan.

PMID:
24499928
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Structure of an HIV-1-neutralizing antibody target, the lipid-bound gp41 envelope membrane proximal region trimer.

Reardon PN, Sage H, Dennison SM, Martin JW, Donald BR, Alam SM, Haynes BF, Spicer LD.

Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):1391-6. doi: 10.1073/pnas.1309842111. Epub 2014 Jan 13.

PMID:
24474763
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies.

Zhang J, Alam SM, Bouton-Verville H, Chen Y, Newman A, Stewart S, Jaeger FH, Montefiori DC, Dennison SM, Haynes BF, Verkoczy L.

J Immunol. 2014 Feb 15;192(4):1693-706. doi: 10.4049/jimmunol.1302511. Epub 2014 Jan 24.

PMID:
24465011
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies.

deCamp A, Hraber P, Bailer RT, Seaman MS, Ochsenbauer C, Kappes J, Gottardo R, Edlefsen P, Self S, Tang H, Greene K, Gao H, Daniell X, Sarzotti-Kelsoe M, Gorny MK, Zolla-Pazner S, LaBranche CC, Mascola JR, Korber BT, Montefiori DC.

J Virol. 2014 Mar;88(5):2489-507. doi: 10.1128/JVI.02853-13. Epub 2013 Dec 18.

PMID:
24352443
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6.

Ofek G, Zirkle B, Yang Y, Zhu Z, McKee K, Zhang B, Chuang GY, Georgiev IS, O'Dell S, Doria-Rose N, Mascola JR, Dimitrov DS, Kwong PD.

J Virol. 2014 Mar;88(5):2426-41. doi: 10.1128/JVI.02837-13. Epub 2013 Dec 11.

PMID:
24335316
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Thermodynamic analysis of the binding of 2F5 (Fab and immunoglobulin G forms) to its gp41 epitope reveals a strong influence of the immunoglobulin Fc region on affinity.

Crespillo S, Casares S, Mateo PL, Conejero-Lara F.

J Biol Chem. 2014 Jan 10;289(2):594-9. doi: 10.1074/jbc.C113.524439. Epub 2013 Dec 3.

PMID:
24302742
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

IgM Repertoire Biodiversity is Reduced in HIV-1 Infection and Systemic Lupus Erythematosus.

Yin L, Hou W, Liu L, Cai Y, Wallet MA, Gardner BP, Chang K, Lowe AC, Rodriguez CA, Sriaroon P, Farmerie WG, Sleasman JW, Goodenow MM.

Front Immunol. 2013 Nov 15;4:373. doi: 10.3389/fimmu.2013.00373. eCollection 2013.

PMID:
24298273
[PubMed]
Free PMC Article
14.

Antigenic properties of the HIV envelope on virions in solution.

Ray K, Mengistu M, Yu L, Lewis GK, Lakowicz JR, DeVico AL.

J Virol. 2014 Feb;88(3):1795-808. doi: 10.1128/JVI.03048-13. Epub 2013 Nov 27. Erratum in: J Virol. 2014 May;88(10):5901. Yu, Lei [added].

PMID:
24284318
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies.

Zhai Y, Zhong Z, Zariffard M, Spear GT, Qiao L.

Vaccine. 2013 Nov 4;31(46):5422-9. doi: 10.1016/j.vaccine.2013.09.003. Epub 2013 Sep 19.

PMID:
24055348
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.

Yi G, Lapelosa M, Bradley R, Mariano TM, Dietz DE, Hughes S, Wrin T, Petropoulos C, Gallicchio E, Levy RM, Arnold E, Arnold GF.

PLoS One. 2013 Sep 6;8(9):e72205. doi: 10.1371/journal.pone.0072205. eCollection 2013.

PMID:
24039745
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1.

Xiang SH.

Curr HIV Res. 2013 Sep;11(6):464-72.

PMID:
24033298
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Antibodies in HIV-1 vaccine development and therapy.

Klein F, Mouquet H, Dosenovic P, Scheid JF, Scharf L, Nussenzweig MC.

Science. 2013 Sep 13;341(6151):1199-204. doi: 10.1126/science.1241144. Review.

PMID:
24031012
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challenge.

Klein K, Veazey RS, Warrier R, Hraber P, Doyle-Meyers LA, Buffa V, Liao HX, Haynes BF, Shaw GM, Shattock RJ.

J Virol. 2013 Nov;87(21):11604-16. doi: 10.1128/JVI.01361-13. Epub 2013 Aug 21.

PMID:
23966410
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10.

Doyle-Cooper C, Hudson KE, Cooper AB, Ota T, Skog P, Dawson PE, Zwick MB, Schief WR, Burton DR, Nemazee D.

J Immunol. 2013 Sep 15;191(6):3186-91. doi: 10.4049/jimmunol.1301285. Epub 2013 Aug 12.

PMID:
23940276
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk